Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/15/2862629/0/en/Applied-Therapeutics-Appoints-Dale-Hooks-as-Chief-Commercial-Officer.html
https://www.biospace.com/article/releases/applied-therapeutics-appoints-dale-hooks-as-chief-commercial-officer/
https://www.globenewswire.com/news-release/2024/04/04/2857643/0/en/Applied-Therapeutics-to-Present-Results-from-Phase-3-ARISE-HF-Study-in-Diabetic-Cardiomyopathy-at-ACC-2024.html
https://www.globenewswire.com/news-release/2024/03/28/2854501/0/en/Applied-Therapeutics-Provides-FDA-Update-on-PDUFA-Target-Action-Date-for-Govorestat-for-the-Treatment-of-Classic-Galactosemia.html
https://www.globenewswire.com//news-release/2024/03/06/2841237/0/en/Applied-Therapeutics-Reports-Fourth-Quarter-and-Year-end-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2024/02/28/2836939/0/en/Applied-Therapeutics-Announces-100-Million-Private-Placement.html
https://www.globenewswire.com//news-release/2024/02/28/2836879/0/en/Applied-Therapeutics-Announces-FDA-Acceptance-and-Priority-Review-of-New-Drug-Application-for-Govorestat-for-the-Treatment-of-Classic-Galactosemia.html
https://www.globenewswire.com//news-release/2024/02/15/2829821/0/en/Applied-Therapeutics-Announces-Positive-Results-from-12-month-Interim-Analysis-of-Govorestat-AT-007-in-the-Ongoing-INSPIRE-Phase-3-Trial-in-Sorbitol-Dehydrogenase-SORD-Deficiency.html
https://www.fiercebiotech.com/biotech/applied-therapeutics-claims-victory-phase-3-sord-fight-plots-path-fda-amid-questions-about
https://www.fiercebiotech.com/biotech/applied-therapeutics-fails-heart-disease-phase-3-seeks-partner-bring-molecule-market